Showing 851-860 of 1009 results for "".
- Allergan Aesthetics Launches New SkinMedica HA5 Hydra Collagen Replenish + Restore Hydratorhttps://modernaesthetics.com/news/allergan-aesthetics-launches-new-skinmedica-ha5-hydra-collagen-replenish-restore-hydrator/2473663/Allergan Aesthetics, an AbbVie company, announced the launch of SkinMedica HA5 Hydra Collagen Replenish + Restore Hydrator. The new product is specifically designed to deliver unparalleled hydration, visible plumpness, and radiance to facial skin. The new SkinMedic
- Fake Doctor Charged After Injuring Woman During Cosmetic Procedure, LA Prosecutors Sayhttps://modernaesthetics.com/news/fake-doctor-charged-after-injuring-woman-during-cosmetic-procedure-la-prosecutors-say/2473661/Cristian Perez Latorre faces assault and battery charges after allegedly impersonating a doctor and performing a cosmetic surgery that led to “great bodily injury in Los Angeles in 2021, the Los Angeles County District Attorney’s Office announced last week. Prosecutors
- Global Laser Resurfacing Industry Market Projected to Reach $649.9Mhttps://modernaesthetics.com/news/global-laser-resurfacing-industry-market-projected-to-reach-6499m/2473660/New research of the global laser resurfacing industry forecasts the market will grow to $649.9 million at a compound annual growth rate of 8.7%. The laser resurfacing market covers a variety of areas in the aesthetics field, including skin tightening, eliminating benign and malign
- Novaestiq’s Partner Croma-Pharma Submits Final Application for Hyaluronic Acid Dermal Fillerhttps://modernaesthetics.com/news/novaestiqs-partner-croma-pharma-submits-final-application-for-hyaluronic-acid-dermal-filler/2473657/Novaestiq Corp., an aesthetic company that focuses on delivering intelligent and innovative skin solutions to practices and patients, announced its partner Croma-Pharma GmbH finalized the submission of its premarket approval to the US Food and Drug Administration (FDA) for the saypha MagIQ hyalur
- Kenvue Introduces Patented Micro-Peptide Technology with Neutrogena Collagen Bank Launchhttps://modernaesthetics.com/news/kenvue-introduces-patented-micro-peptide-technology-with-neutrogena-collagen-bank-launch/2473651/Kenvue announced the launch of Neutrogena Collagen Bank featuring the company’s patented micro-peptide technology. The launch brings Neutrogena into the pre-aging catefory and is poised to meet the needs of Gen Z, a new generation of consumers. Neutrogena Collagen Bank aims
- L’Oréal Eyes Aesthetics Market with Acquisition of Minority Stake in Galdermahttps://modernaesthetics.com/news/loreal-eyes-aesthetics-market-with-acquisition-of-galderma/2473646/Major beauty brand L’Oréal announced the acquisition of a 10% stake in Galderma, a Swiss pharmaceutical company. The two companies have agreed to work towards a strategic scientific partnership that will leverage the undisputed expertise of both companies, according to a press releas
- Dermal Fillers Global Marketing Rising in Demandhttps://modernaesthetics.com/news/dermal-fillers-global-marketing-rising-in-demand/2473640/The dermal fillers global market size is expected to grow from almost $4 billion over the next seven years, reaching an estimated $7.58 billion by 2031. It’s anticipated to register a compound annual growth rate of 8.3% during the forecasted period, according to Premium Market Insights.&nbs
- Allergen Aesthetics Brings Back JUVÉDERM® Dayhttps://modernaesthetics.com/news/allergen-aesthetics-brings-back-juvederm-day/2473639/Allergan Aesthetics announced the return of JUVÉDERM® Day on Wednesday, August 21. The event, held for the first time last year, features limited-time offers, savings, and exclusive deals through Allē, the Allergan Aesthetics loyalty rewards program.
- First, Only US Neurotoxin for Simultaneous Treatment of Upper Facial Lines Gets FDA Approvalhttps://modernaesthetics.com/news/first-only-us-neurotoxin-for-simultaneous-treatment-of-upper-facial-lines-gets-fda-approval/2473638/Merz Aesthetics announced the US Food and Drug Administration approved XEOMIN (incobotulinumtoxinA) as the first and only neurotoxin for the simultaneous treatment of upper facial lines – forehead lines, frown lines, and crow’s feet. XEOMIN was first approved in 2011 f
- Aesthetic Lasers and Energy Devices Market Size to Grow By $2.37Bhttps://modernaesthetics.com/news/aesthetic-lasers-and-energy-devices-market-size-to-grow-by-237b-5/2473637/The global aesthetics laser and energy devices market size is estimated to grow by $2.37 billion from 2024 to 2028. Technavio report the market will grow at a compound annual growth rate of almost 10.87% during the next four years. A key factor driving growth in the market is the